News Focus
News Focus
icon url

justdafactss

02/10/20 10:11 AM

#98214 RE: Adamb2 #98212

Yes Adam, the market figured it all out.

A middleman attempting to sell 3-5x retail markup overpriced kits.

Hence .07 to .0001 then 1/150 reverse split, all fully acknowledged by the market, consumers, and the company itself.
icon url

uvaphd

02/10/20 10:12 AM

#98215 RE: Adamb2 #98212

+100. Is this why they STILL haven’t explained clearly BASIC questions—despite the fact that some of us have been beating the drum for 2 years? As I said a couple weeks ago, why would a potential buyer waste its time with CMTH?: just buy out the manufacturer of the device. As for the procedure, what’s to stop practitioners from using that device and *a procedure*—provided that they don’t call THEIRS “CaverStem.”
icon url

Gisano

02/10/20 10:12 AM

#98216 RE: Adamb2 #98212

Scalability is the key question and concern - cmth has not addressed any real plan to grow.
icon url

monte379

02/10/20 10:26 AM

#98220 RE: Adamb2 #98212

I think we have all questioned it. In some ways, it’s super simple. Hold the patents and offer the the use of those services.

Participation means all physicians source the kit through them.

CMTH holds no inventory and just gets their cut by administering the process.

CMTH has little overhead by not having brick and mortar locations.

Super simple and easy if enough physicians join.

That has been the problem to date IMO.

Now that the paper is out we have seen three more offices open. If that is the trend, they will have their revs soon enough IMO.